These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9595892)

  • 1. Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
    Heiden A; de Zwaan M; Frey R; Presslich O; Kasper S
    J Psychiatry Neurosci; 1998 May; 23(3):179-80. PubMed ID: 9595892
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

  • 3. Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
    Nagata T; Ono K; Nakayama K
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):434-6. PubMed ID: 17610670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine in anorexia nervosa.
    Lee S
    J Clin Psychiatry; 1991 May; 52(5):240-1. PubMed ID: 2033033
    [No Abstract]   [Full Text] [Related]  

  • 5. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia nervosa and obsessive-compulsive disorder in a prepubertal patient with bone dysplasia: a case report.
    Lázaro L; Moreno E; Baos P; Castro J
    Int J Eat Disord; 2005 Apr; 37(3):275-7. PubMed ID: 15822084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive and eating disorders: comparison of clinical and personality features.
    Jiménez-Murcia S; Fernández-Aranda F; Raich RM; Alonso P; Krug I; Jaurrieta N; Alvarez-Moya E; Labad J; Menchón JM; Vallejo J
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):385-91. PubMed ID: 17610663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive schizotypal symptoms predict treatment outcome in obsessive-compulsive disorder.
    Moritz S; Fricke S; Jacobsen D; Kloss M; Wein C; Rufer M; Katenkamp B; Farhumand R; Hand I
    Behav Res Ther; 2004 Feb; 42(2):217-27. PubMed ID: 14975782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of low-dose neuroleptics in the treatment of "schizo-obsessive" patients.
    Schulz SC
    Am J Psychiatry; 1986 Oct; 143(10):1318-9. PubMed ID: 2876650
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine in treatment-refractory obsessive-compulsive disorder with comorbid schizotypal personality disorder.
    Poyurovsky M
    Isr J Psychiatry Relat Sci; 2008; 45(3):219-20. PubMed ID: 19398826
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anorexia nervosa and obsessive-compulsive disorder in a young Russian immigrant].
    Iancu I; Kikenzon L; Ratzoni G; Apter A
    Harefuah; 1993 Apr; 124(8):477-9, 527, 526. PubMed ID: 8335272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications.
    Poyurovsky M; Koran LM
    J Psychiatr Res; 2005 Jul; 39(4):399-408. PubMed ID: 15804390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K; Aoki M
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant obsessive-compulsive disorder and schizotypal personality disorder.
    Jenike MA; Baer L; Minichiello WE; Schwartz CE; Carey RJ
    Am J Psychiatry; 1986 Apr; 143(4):530-2. PubMed ID: 3953896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ; Goodman WK; Price LH; Delgado PL; Krystal JH; Charney DS; Heninger GR
    Am J Psychiatry; 1990 May; 147(5):652-4. PubMed ID: 1970224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapeutic Considerations in the Treatment of an Adolescent with Anorexia Nervosa and Obsessive Compulsive Disorder.
    Rice T; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):444-7. PubMed ID: 26091198
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxetine efficacy in stuttering treatment.
    Boldrini M; Rossi M; Placidi GF
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):311-2. PubMed ID: 12975000
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistent obsessive-compulsive disorder and schizotypal personality disorder: a poor prognostic indicator.
    Jenike MA; Baer L; Minichiello WE; Schwartz CE; Carey RJ
    Arch Gen Psychiatry; 1986 Mar; 43(3):296. PubMed ID: 3954553
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
    Sevincok L; Uslu A; Kaynak H; Dereboy F
    J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders.
    Halmi KA; Tozzi F; Thornton LM; Crow S; Fichter MM; Kaplan AS; Keel P; Klump KL; Lilenfeld LR; Mitchell JE; Plotnicov KH; Pollice C; Rotondo A; Strober M; Woodside DB; Berrettini WH; Kaye WH; Bulik CM
    Int J Eat Disord; 2005 Dec; 38(4):371-4. PubMed ID: 16231356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.